Cargando…
Enhanced Recovery after an Innovative Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Spinal Stenosis: A Prospective Observational Study
BACKGROUND: The objective of this study was to investigate the enhanced recovery clinical effects of an innovative percutaneous endoscopic transforaminal lumbar interbody fusion (PE-TLIF) for the treatment of patients with LSS and degenerative instability. METHODS: From January 2019 to March 2020, 5...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712142/ https://www.ncbi.nlm.nih.gov/pubmed/34966474 http://dx.doi.org/10.1155/2021/7921662 |
_version_ | 1784623501638893568 |
---|---|
author | Yin, Peng Gao, Haifeng Zhou, Lijin Pang, Daming Hai, Yong Yang, Jincai |
author_facet | Yin, Peng Gao, Haifeng Zhou, Lijin Pang, Daming Hai, Yong Yang, Jincai |
author_sort | Yin, Peng |
collection | PubMed |
description | BACKGROUND: The objective of this study was to investigate the enhanced recovery clinical effects of an innovative percutaneous endoscopic transforaminal lumbar interbody fusion (PE-TLIF) for the treatment of patients with LSS and degenerative instability. METHODS: From January 2019 to March 2020, 51 patients with single-segment LSS and degenerative instability were prospectively included in our study (ChiCTR1900020679). The Oswestry Disability Index (ODI), the visual analogue scale (VAS) on lumbar and leg pain (VAS-LBP and VAS-LP), serum creatine kinase (CK), the peak intensity of sulphur hexafluoride microbubble contrast agent (PI), and the maximal cross-sectional area of multifidus muscle (Max-CSA) around the surgical incision were assessed preoperatively, postoperatively, and at regular follow-up. RESULTS: All patients were followed up. The mean postoperative bedridden time was 20.45 ± 2.66 hours. The ODI, VAS-LBP, and VAS-LP were improved significantly after operation compared to these data before operation in all the patients (P < 0.05). The CK at 1 day after operation was higher compared to the data before the operation (P < 0.05), and there was no significant difference on CK at 1 week after operation (P > 0.05). The PI at 1 week after operation was higher compared to this item before operation (P < 0.05), and there was no significant difference on PI at 1 month or 3 months after operation (P > 0.05). The Max-CSA at 1 week after operation was higher compared to this item before the operation (P < 0.05), and there was no significant difference in Max-CSA at 1 month or 3 months after operation compared with before the operation (P > 0.05). CONCLUSIONS: Our results and systematic review presented the innovative PE-TLIF technique could obtain satisfactory and effective outcomes for the treatment of patients with LSS and degenerative instability. Our PE-TLIF technique also had the ability to decrease the MF injury and obtain an enhanced recovery. |
format | Online Article Text |
id | pubmed-8712142 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-87121422021-12-28 Enhanced Recovery after an Innovative Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Spinal Stenosis: A Prospective Observational Study Yin, Peng Gao, Haifeng Zhou, Lijin Pang, Daming Hai, Yong Yang, Jincai Pain Res Manag Research Article BACKGROUND: The objective of this study was to investigate the enhanced recovery clinical effects of an innovative percutaneous endoscopic transforaminal lumbar interbody fusion (PE-TLIF) for the treatment of patients with LSS and degenerative instability. METHODS: From January 2019 to March 2020, 51 patients with single-segment LSS and degenerative instability were prospectively included in our study (ChiCTR1900020679). The Oswestry Disability Index (ODI), the visual analogue scale (VAS) on lumbar and leg pain (VAS-LBP and VAS-LP), serum creatine kinase (CK), the peak intensity of sulphur hexafluoride microbubble contrast agent (PI), and the maximal cross-sectional area of multifidus muscle (Max-CSA) around the surgical incision were assessed preoperatively, postoperatively, and at regular follow-up. RESULTS: All patients were followed up. The mean postoperative bedridden time was 20.45 ± 2.66 hours. The ODI, VAS-LBP, and VAS-LP were improved significantly after operation compared to these data before operation in all the patients (P < 0.05). The CK at 1 day after operation was higher compared to the data before the operation (P < 0.05), and there was no significant difference on CK at 1 week after operation (P > 0.05). The PI at 1 week after operation was higher compared to this item before operation (P < 0.05), and there was no significant difference on PI at 1 month or 3 months after operation (P > 0.05). The Max-CSA at 1 week after operation was higher compared to this item before the operation (P < 0.05), and there was no significant difference in Max-CSA at 1 month or 3 months after operation compared with before the operation (P > 0.05). CONCLUSIONS: Our results and systematic review presented the innovative PE-TLIF technique could obtain satisfactory and effective outcomes for the treatment of patients with LSS and degenerative instability. Our PE-TLIF technique also had the ability to decrease the MF injury and obtain an enhanced recovery. Hindawi 2021-12-20 /pmc/articles/PMC8712142/ /pubmed/34966474 http://dx.doi.org/10.1155/2021/7921662 Text en Copyright © 2021 Peng Yin et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Yin, Peng Gao, Haifeng Zhou, Lijin Pang, Daming Hai, Yong Yang, Jincai Enhanced Recovery after an Innovative Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Spinal Stenosis: A Prospective Observational Study |
title | Enhanced Recovery after an Innovative Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Spinal Stenosis: A Prospective Observational Study |
title_full | Enhanced Recovery after an Innovative Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Spinal Stenosis: A Prospective Observational Study |
title_fullStr | Enhanced Recovery after an Innovative Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Spinal Stenosis: A Prospective Observational Study |
title_full_unstemmed | Enhanced Recovery after an Innovative Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Spinal Stenosis: A Prospective Observational Study |
title_short | Enhanced Recovery after an Innovative Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Spinal Stenosis: A Prospective Observational Study |
title_sort | enhanced recovery after an innovative percutaneous endoscopic transforaminal lumbar interbody fusion for the treatment of lumbar spinal stenosis: a prospective observational study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712142/ https://www.ncbi.nlm.nih.gov/pubmed/34966474 http://dx.doi.org/10.1155/2021/7921662 |
work_keys_str_mv | AT yinpeng enhancedrecoveryafteraninnovativepercutaneousendoscopictransforaminallumbarinterbodyfusionforthetreatmentoflumbarspinalstenosisaprospectiveobservationalstudy AT gaohaifeng enhancedrecoveryafteraninnovativepercutaneousendoscopictransforaminallumbarinterbodyfusionforthetreatmentoflumbarspinalstenosisaprospectiveobservationalstudy AT zhoulijin enhancedrecoveryafteraninnovativepercutaneousendoscopictransforaminallumbarinterbodyfusionforthetreatmentoflumbarspinalstenosisaprospectiveobservationalstudy AT pangdaming enhancedrecoveryafteraninnovativepercutaneousendoscopictransforaminallumbarinterbodyfusionforthetreatmentoflumbarspinalstenosisaprospectiveobservationalstudy AT haiyong enhancedrecoveryafteraninnovativepercutaneousendoscopictransforaminallumbarinterbodyfusionforthetreatmentoflumbarspinalstenosisaprospectiveobservationalstudy AT yangjincai enhancedrecoveryafteraninnovativepercutaneousendoscopictransforaminallumbarinterbodyfusionforthetreatmentoflumbarspinalstenosisaprospectiveobservationalstudy |